- Is latanoprost more effective for hair regrowth than minoxidil? No trial has compared latanoprost and minoxidil head to head. Minoxidil has large randomized trials and FDA approval for hair loss, while latanoprost's scalp evidence is a single 24-week pilot in 16 men, so the published evidence does not support latanoprost being the more effective option.
- How does bimatoprost compare to minoxidil for hair regrowth? Minoxidil is FDA-approved for scalp hair loss and backed by decades of large trials; bimatoprost is approved only for eyelashes, and the published scalp evidence is limited to small short studies, so on the scalp it is off-label and experimental.
- Can I use clascoterone if I'm undergoing gender-affirming hormone therapy? No published clinical trial has tested clascoterone in people on gender-affirming hormone therapy, so its safety in that group is unknown. The FDA label reports low systemic exposure and no described effect on blood testosterone, but it also records HPA-axis suppression and raised potassium in a small minority of subjects.
- GHK-Cu: What is the most recommended product? No GHK-Cu product has published human trial evidence for hair loss, so none can be ranked on efficacy; what separates products is formulation quality — purity, stability and third-party testing — and the FDA lists GHK-Cu among bulk substances that may present significant safety risks in compounding.
- Alfatradiol: What does a form of estrogen have to do with hair loss in men? Alfatradiol (17α-estradiol) is a prescription topical hormone, licensed for androgenetic alopecia in Germany but not FDA-approved. The controlled trial evidence is in women, where it produced stabilisation rather than regrowth and was outperformed by minoxidil; no comparable placebo-controlled trial in men appears to have been published.
a potent but unapproved and potentially problematic topical anti-androgen
mTOR regulator and immunosuppressant used more recently for anti-aging and hair regrowth
much-hyped research compound targeting prolactin receptor in scalp
laser therapy for anti-inflammatory and likely insignificant hair regrowth effects
